Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Datamonitor
|
$175.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Market Edge
|
$10.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$115.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
DaVita Inc Raises FY 2012 EBIT Guidance; Issues FY 2013 EBIT Guidance Below Analysts' Estimates
DaVita Inc announced that for fiscal 2012, it expects EBIT to be in the range of $1,315-$1,330 million. For fiscal 2013, it expects EBIT to be in the range of $1,350-$1,450 million. According to I/B/E/S Estimates, analysts are expecting the Company to report EBIT of $1,331 million for fiscal 2012; EBIT of $1,463 million for fiscal 2013.
Latest Developments for DaVita HealthCare Partners Inc
- DaVita HealthCare Partners Inc Raises Low End Of Prior FY 2013 EBIT Guidance To A Range In Line With Analysts' Estimates
- DaVita HealthCare Partners Inc Reaffirms FY 2013 EBIT Guidance
- BioScrip Inc Closes Acquisition of DaVita HealthCare Partners Inc's Subsidiary HomeChoice Partners Inc
- BioScrip Inc Enters Into Agreement To Acquire DaVita HealthCare Partners Inc's HomeChoice Partners, Inc.
Latest Key Developments in Healthcare
- Share this
- Link this
- Digg this
Follow Reuters